VanA-Type Staphylococcus aureus Strain VRSA-7 Is Partially Dependent on Vancomycin for Growth
- 1 September 2009
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (9), 3657-3663
- https://doi.org/10.1128/aac.00338-09
Abstract
VanA-type Staphylococcus aureus strain VRSA-7 was partially dependent on glycopeptides for growth. The vanA gene cluster, together with the erm(A) and the ant(9)-Ia resistance genes, was carried by the ca. 35- to 40-kb conjugative plasmid pIP848 present at five copies per cell. The chromosomal ddl gene had a mutation that led to a N308K substitution in the d-Ala:d-Ala ligase that resulted in a 1,000-fold decrease in activity relative to that of strain VRSA-6. Strain VRSA-7 grown in the absence or in the presence of vancomycin mainly synthesized precursors ending in d-Ala-d-Lac, indicating that the strain relied on the vancomycin resistance pathway for peptidoglycan synthesis. Greatly enhanced growth in the presence of glycopeptides and the absence of mutations in the genes for VanR and VanS indicated the inducible expression of resistance. Thus, a combination of loose regulation of the vanA operon by the two-component system and a gene dosage effect accounts for the partial glycopeptide dependence of VRSA-7. Since peptidoglycan precursors ending in d-Ala-d-Lac are not processed by PBP 2′, the strain was fully susceptible to oxacillin, despite the production of a wild-type PBP 2′.This publication has 50 references indexed in Scilit:
- Vancomycin-Resistant Staphylococcus aureus Isolates Associated with Inc18-Like vanA Plasmids in MichiganAntimicrobial Agents and Chemotherapy, 2008
- Synergism between β-Lactams and Glycopeptides against VanA-Type Methicillin-Resistant Staphylococcus aureus and Heterologous Expression of the vanA OperonAntimicrobial Agents and Chemotherapy, 2006
- Allosteric inhibition of Staphylococcus aureus d -alanine: d -alanine ligase revealed by crystallographic studiesProceedings of the National Academy of Sciences of the United States of America, 2006
- Successful Therapy of Experimental Endocarditis Caused by Vancomycin-Resistant Staphylococcus aureus with a Combination of Vancomycin and β-Lactam AntibioticsAntimicrobial Agents and Chemotherapy, 2006
- Influence of Transferable Genetic Determinants on the Outcome of Typing Methods Commonly Used for Enterococcus faeciumJournal of Clinical Microbiology, 2003
- The vanZ gene of Tn1546 from enterococcus faecium BM4147 confers resistance to teicoplaninGene, 1995
- Modified peptidoglycan precursors produced by glycopeptide-resistant enterococciFEMS Microbiology Letters, 1992
- Antibody used to identify penicillin-binding protein 2' in methicillin-resistant strains ofStaphylococcus aureus(MRSA)FEBS Letters, 1987
- The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophageNature, 1983
- PENICILLINASE PRODUCTION AND INTRINSIC RESISTANCE TO PENICILLINS IN STAPHYLOCOCCUS AUREUSThe Lancet, 1966